Actively Recruiting
Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
Led by Zhongshan Ophthalmic Center, Sun Yat-sen University · Updated on 2025-05-23
10000
Participants Needed
4
Research Sites
N/A
Total Duration
On this page
Sponsors
Z
Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead Sponsor
T
The First Affiliated Hospital of Guangzhou Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are exploring whether eye examinations combined with big data and artificial intelligence can help in early screening and diagnosis of lung diseases. The study involves people with and without lung conditions to see if eye exam results can assist in identifying disease types and predicting outcomes. This observational study is sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. Participants will undergo various eye tests including slit lamp photography, fundus photography, optical coherence tomography imaging, and optical coherence tomography angiography. They will also have lung-related examinations such as chest X-rays, CT scans, and lung function tests. The study includes a test group with lung diseases and a control group without these diseases. Throughout the study, participants will have regular eye and lung exams and follow-up visits. The main measurement is the area under the receiver operating characteristic curve assessed over about one year. Researchers will monitor results to evaluate how well eye exams combined with artificial intelligence can support lung disease screening and prognosis. The study is expected to last until May 2026.
CONDITIONS
Brief Title
Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older, or under 18 but able to cooperate and accompanied by a guardian
- Have a respiratory-related disease and undergoing pulmonary examination, or volunteer through recruitment
- Expected survival time of 3 months or more
- No serious underlying diseases or history of serious eye diseases
- Able to cooperate with eye and lung examinations and attend regular follow-up visits
- Voluntarily signed informed consent before joining
- Other conditions deemed acceptable by the investigator
You will not qualify if you...
- Unable to complete eye or lung exams and regular follow-ups due to serious diseases, trauma, or surgery
- Serious eye diseases preventing eye examination (e.g., extremely poor vision, ocular atrophy, severe clouding preventing fundus photography)
- Poor compliance due to alcohol or drug dependence, or mental disorders
- Did not give informed consent
- Other conditions judged unsuitable by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants undergo various ophthalmic and pulmonary examinations to assist in pulmonary disease diagnosis.
Regular visits for ophthalmic and pulmonary examinations during the study period
Trial Site Locations
Total: 4 locations
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060
Actively Recruiting
2
Guangzhou Kindness Health Care Center (Guangzhou Jiubang Shanxin Clinic Ltd)
Guangzhou, Guangdong, China
Actively Recruiting
3
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Actively Recruiting
4
Shenzhen Third People's Hospital
Shenzhen, Guangdong, China
Actively Recruiting
Research Team
W
Weixing Zhang, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here